1. "Pediatrics, Department of"
Formats
  1. Journal Article (2874)
  2. Meeting Abstract (1908)
  3. Review (135)
  4. Book Section (123)
  5. Editorial (61)
  6. Conference Paper (53)
  7. Research Letter (33)
  8. Correspondence (25)
  9. Guidelines (23)
  10. Miscellaneous (11)
  11. Book Whole (4)
Groups
  1. Pediatrics, Department of (5250)
  2. Tow Center for Developmental Oncology (TCDO) (2073)
  3. GSK Faculty (1984)
  4. Center for Hematologic Malignancies (1906)
  5. Stem Cell Transplantation and Cellular Therapy Service (1636)
  6. Department of Medicine (1584)

More Groups

People
  1. Richard O'Reilly (748)
  2. Nai-Kong Cheung (648)
  3. Nancy Kernan (512)
  4. Michael La Quaglia (411)
  5. David Abramson (388)
  6. Ira Dunkel (371)

More People

Years
  1. 2025 (91)
  2. 2024 (231)
  3. 2023 (272)
  4. 2022 (332)
  5. 2021 (278)
  6. 2020 (323)

More Years

Publications
  1. Blood (608)
  2. Journal of Clinical Oncology (430)
  3. Pediatric Blood and Cancer (416)
  4. Biology of Blood and Marrow Transplantation (265)
  5. Neuro-Oncology (235)
  6. Cancer Research (129)

More Publications

Publishers
  1. American Society of Hematology (663)
  2. Elsevier Inc. (658)
  3. American Society of Clinical Oncology (463)
  4. Wiley Periodicals, Inc (430)
  5. Oxford University Press (338)
  6. American Association for Cancer Research (317)

More Publishers

Results (5250)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radioimmunotherapy with intraventricular (131)I-omburtamab in patients with central nervous system (CNS) neuroblastoma: Interim results from a multinational trial
    Meeting Abstract

    Kramer, K.; Mora, J.; Bear, M.; Zanzonico, P.; Pandit-Taskar, N.; During, M.; Fabricius, S.; Streby, K.; Rømer, J.
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Relapse SHH medulloblastoma (MB) in young children. Are there alternatives to full-dose craniospinal irradiation?
    Meeting Abstract

    Erker, C.; Craig, B.; Bailey, S.; Massimino, M.; Larouche, V.; Finlay, J.; Kline, C.; Michaiel, G.; Margol, A.; Cohen, K.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma
    Meeting Abstract

    Rosenberg, T.; Yeo, K. K.; Mauguen, A.; Alexandrescu, S.; Prabhu, S. P.; Tsai, J. W.; Malinowski, S.; Joshirao, M.; Parikh, K.; Sait, S. F.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Erdafitinib in pediatric patients with advanced solid tumors with fibroblast growth factor receptor (FGFR) gene alterations: RAGNAR study pediatric cohort
    Meeting Abstract

    Witt, O.; Geoerger, B.; Dirksen, U.; Sait, S. F.; Reardon, D. A.; Shih, K. C.; Diez, B. D.; Caran, E. M. M.; Karakawa, S.; Stuyckens, K.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Outcomes of Hispanic and non-Hispanic white pediatric and young adult patients with B-cell acute lymphoblastic leukemia after commercial tisagenlecleucel
    Meeting Abstract

    Vandris, P.; Chao, K.; Baggott, C.; Phillips, C. L.; Qayed, M.; Rossoff, J.; Lim, S. J. S.; Winestone, L. E.; Stefanski, H. E.; Talano, J. A. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma
    Meeting Abstract

    Slotkin, E. K.; Mauguen, A.; Ortiz, M. V.; Dela Cruz, F. S.; O'Donohue, T.; Kinnaman, M. D.; Meyers, P. A.; Wexler, L. H.; Rodriguez, S.; Avutu, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Presence of immune infiltrates, increased expression of transposable elements, and viral response pathways in sarcoma associate with response to checkpoint inhibition
    Meeting Abstract

    Nacev, B. A.; Bradic, M.; Richards, A. L.; Kelly, C. M.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Chi, P.; Movva, S.; Thornton, K. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Naxitamab (NAX) treatment for refractory/relapsed (R/R) high-risk neuroblastoma (HRNB): Response data and efficacy in patient (pt) subgroups
    Meeting Abstract

    Mora, J.; Chan, G. C. F.; Morgenstern, D. A.; Nysom, K.; Bear, M.; Tornøe, K.; Sørensen, P. S.; Kushner, B. H.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Novel infusion strategy to reduce major side effects caused by anti-GD2 monoclonal antibody naxitamab without affecting its pharmacokinetics
    Meeting Abstract

    Mora, J.; Varo, A.; Castañeda, A.; Chamorro, S.; Muñoz, J. P.; Gorostegui, M.; Celma, M. S.; Lopez, S.; Simao, M.; Perez-Jaume, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Results of "HITS" phase II study
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Mauguen, A.; Castañeda, A.; Varo, A.; Gorostegui, M.; Muñoz, J. P.; Santa-Maria, V.; Basu, E. M.; Cardenas, F. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save